tert-Butyl L-valinate | CAS:13211-31-9

We serve tert-Butyl L-valinate CAS:13211-31-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
tert-Butyl L-valinate

Chemical Name:  tert-Butyl L-valinate
CAS.NO: 13211-31-9
Molecular Formula:C9H19NO2
Molecular Weight: 173.25300

Synonyms:
H-D-VAL-OTBU HCL
H-L-Val-OtBu
L-Valine tert-butyl ester hydrochloride
(S)-Valine tert-butyl ester
L-Valine tert-butyl
NH2-L-Val-OtBu
H-Val-OButCl
tert-Butyl L-valinat
(L)-valine tert-butyl ester
D-VALINE-OTBU HCL
L-tBu-Val-NH2
L-valine t-butyl ester
L-VALINE T-BUTYL ESTER HCL
Val-OtBu HCl

Physical and Chemical Properties:
Density: 0.936g / cm3
Boiling point: 241.7ºC at 760 mmHg
Flash point: 100ºC
Refractive index: 1.441

Specification:
Appearance: White powder
Purity:≥98%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:-15ºC. Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:Pharmaceutical intermediates.



Contact us for information like tert-Butyl L-valinate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Val-OtBu HCl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Val-OtBu HCl Use and application,L-valine t-butyl ester technical grade,usp/ep/jp grade.


Related News: The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.4-benzyl-2-hydroxymorpholin-3-one manufacturer By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.METHYL 2-ISOTHIOCYANATO PROPIONATE supplier By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.(R)-2,3-Dihydro-1H-Inden-1-Amine Hydrochloride vendor Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.